Search Results - "Oertel, Maryann D"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Fondaparinux and the Management of Heparin-Induced Thrombocytopenia: The Journey Continues by Blackmer, Allison Beck, Oertel, Maryann D, Valgus, John M

    Published in The Annals of pharmacotherapy (01-10-2009)
    “…Objective: To review the available literature addressing the role of fondaparinux in the management of heparin-induced thrombocytopenia (HIT). Data Sources:…”
    Get full text
    Journal Article
  2. 2

    Allopurinol as Adjuvant Therapy in Poorly Responsive or Treatment Refractory Schizophrenia by Buie, Larry W, Oertel, Maryann D, Cala, Suzanne O

    Published in The Annals of pharmacotherapy (01-12-2006)
    “…Objective: To review the available literature evaluating the effectiveness of allopurinol for poorly responsive or treatment refractory schizophrenia. Data…”
    Get full text
    Journal Article
  3. 3

    Reflections on the use of electronic health record data for clinical research by West, Suzanne L, Blake, Catherine, Zhiwen Liu, McKoy, J Nikki, Oertel, Maryann D, Carey, Timothy S

    Published in Health informatics journal (01-06-2009)
    “…The adoption of electronic health records (EHRs) offers the potential to improve the delivery, quality, and continuity of clinical care, but widespread use has…”
    Get more information
    Journal Article
  4. 4

    Evaluation of Outcomes in Converting from Intravenous Ondansetron to Oral Granisetron: An Observational Study by McCune, Jeannine S, Oertel, Maryann D, Pfeifer, Dennis, Houston, Shelly A, Bingham, Andrea, Sawyer, William T, Lindley, Celeste M

    Published in The Annals of pharmacotherapy (01-01-2001)
    “…OBJECTIVE: To describe a systematic evaluation of the outcomes associated with revising institutional guidelines for the prevention of acute…”
    Get full text
    Journal Article
  5. 5

    Anagrelide, a selective thrombocytopenic agent by Oertel, MD

    Published in American journal of health-system pharmacy (01-10-1998)
    “…The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of anagrelide are reviewed. Anagrelide is a selective…”
    Get full text
    Journal Article
  6. 6

    RespiGam: an RSV immune globulin by Oertel, M D

    Published in Pediatric nursing (01-11-1996)
    “…Respiratory syncytial virus immune globulin has been shown to prevent or attenuate RSV lower respiratory tract infection in infants under 24 months of age with…”
    Get more information
    Journal Article
  7. 7

    Synagis: an anti-RSV monoclonal antibody by Driver, L C, Oertel, M D

    Published in Pediatric nursing (01-09-1999)
    “…Palivizumab is a new anti-RSV monoclonal antibody product indicated for the prevention of serious lower respiratory tract disease caused by RSV in pediatric…”
    Get more information
    Journal Article
  8. 8